Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Disintegrin variants and their use in treating osteoporosis-induced bone loss and angiogenesis-related diseases

Disintegrin variants and their use in treating osteoporosis-induced bone loss and angiogenesis-related diseases

US Patent 7943728 · Granted May 17, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for the treatment of Alzheimer's disease2025
Fibronectin type III domain-based protein and application thereof2025
Compounds for the treatment of Alzheimer's disease2024
Disintegrin variants and uses thereof2021
Disintegrin variants and uses thereof2021
Disintegrin variants and pharmaceutical uses thereof2020
Brain penetrant amylin receptor based peptides for Alzheimer's disease2020
Methods for treating angiogenesis related disorder2020
Disintegrin variants and pharmaceutical uses thereof2019
Modified fibronectin fragments or variants and uses thereof2018
Peptide compounds for inhibitions of platelet aggregation2018
Antibodies and method for determining deletions in HBV pre-S2 region2017